Summary

A long-term extension trial demonstrated improvement in urinary incontinence (UI) as a result of neurogenic detrusor overactivity (NDO) caused by multiple sclerosis (MS). This article presents data from A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis trial [NCT00876447; Aliotta PJ et al. ACTRIMS/ECTRIMS 2014; (poster P905)].